SZSvitlana Zhuk

Svitlana Zhuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Svitlana Zhuk has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative clinical and microbiological efficacy of Tergynan versus a combined nitroimidazole-free medication in patients with bacterial vaginosis

    by S.I. Zhuk, D.D. Andreishyna, K.I. Derba

    The objective: to compare the clinical and microbiological efficacy of Tergynan and a combined medication without a nitroimidazole component in patients with bacterial vaginosis.Materials and methods. This prospective, randomized, open-label, comparative study included 80 women of reproductive age with clinically and laboratory-confirmed bacterial vaginosis. Patients were randomized into two groups: group I (n = 40) received intravaginally Tergynan for 10 days, group II (n = 40) – a combined medication without a nitroimidazole component for 12 days. The diagnosis was established using the Amsel criteria combined with assessment of Gram-stained vaginal smear according to the Nugent score. Efficacy of treatment was assessed after completion of treatment and 30 days later based on the dynamics of clinical symptoms, vaginal smear microscopy, and recurrence rate.Results. Clinical and microbiological recovery after treatment was achieved in 85.0% of patients in group I and 60.0% in group II (p = 0.012). Resolution or marked reduction of clinical symptoms was observed in 90.0% and 67.5% of patients, respectively (p = 0.014). Normalization or marked improvement of vaginal smear microscopy was found in 85.0% and 60.0% of patients, respectively. After treatment, the mean Nugent score was 3.2 ± 1.4 in group I and 4.8 ± 1.8 in group II (p < 0.001). After 30 days, bacterial vaginosis recurrence was recorded in 12.5% of patients in group I and 32.5% in group II (p = 0.032). No serious adverse reactions were observed.Conclusions. Tergynan therapy was associated with higher clinical and microbiological efficacy and a lower recurrence rate during the 30-day follow-up period compared with the combined medication without a nitroimidazole component.

  • Open Access

    Pregnancy outcomes in internally displaced women and the possibilities of correcting inflammation­ associated complications: results of a prospective study

    by Karina Derba, Svitlana Zhuk

    Objective: To evaluate the effect of complex therapy on pregnancy outcomes and inflammation-associated complications in internally displaced women. Materials and Methods:A prospective controlled study included 84 pregnant internally displaced women with chronic inflammatory conditions of the genital tract. Participants were enrolled at 12–22 weeks of gestation and divided into two groups: Group I (n=42) received standard antenatal care, while Group II (n=42) received standard care combined with complex therapy, including micronized progesterone, omega-3 fatty acids, and local vaginal treatment. Statistical significance was set at p<0.05. Results: Complex therapy was associated with a significant reduction in inflammation-associated complications. The incidence of threatened preterm labor and premature rupture of membranes decreased by approximately 1.8–2.4-fold, placental dysfunction nearly twofold, and preterm birth more than twofold. These effects were accompanied by reduced systemic inflammation, reflected by lower C-reactive protein levels, and improved vaginal microbiota. Neonatal outcomes were more favorable, including higher birth weight and improved Apgar scores. Conclusions: Complex therapy targeting inflammatory, hormonal, and local infectious mechanisms reduces pregnancy complications and improves perinatal outcomes in internally displaced women.

  • Open Access

    Prediction of fetal anemia dynamics and justification of intervals between intrauterine transfusions in Rh­alloimmunized pregnancies

    by Svitlana Zhuk, Yurii Melnyk, Mariia Kryvoruk

    The objective: to identify prognostic factors influencing the dynamics of fetal anemia and to substantiate the intervals between intrauterine transfusions (IUTs) in Rh-alloimmunized pregnancies based on a comprehensive clinical and instrumental analysis. Materials and methods. A retrospective descriptive and analytical study was conducted in 27 pregnancies complicated by Rh alloimmunization, in which 63 cordocenteses with IUTs were performed during 2024–2026. The following parameters were analyzed: gestational age at each intervention, dynamics of maternal anti-Rh antibody titers, middle cerebral artery peak systolic velocity (MCA-PSV), invasively determined fetal hemoglobin and hematocrit levels, transfusion volume, intervals between procedures, placental location, and technical aspects of the interventions. Results. The intervals between IUTs were determined by a combination of gestational age, invasively measured fetal hemoglobin level, MCA-PSV values, and the presence of structural ultrasound markers of fetal anemia. Placental location influenced the technical performance of the procedure and the profile of postprocedural risks. Following repeated IUTs, some fetuses demonstrated discordance between MCA-PSV values and fetal hemoglobin levels, which likely reflects specific features of cerebral hemodynamic adaptation after repeated transfusions. Comprehensive assessment of ultrasound and laboratory parameters allowed individualized determination of the timing between repeated IUTs. Conclusions. Determination of intervals between IUTs in Rh alloimmunization should be based on an integrated assessment of gestational age, invasively measured fetal hemoglobin level, hemodynamic and structural ultrasound markers of anemia, as well as technical procedural factors. Isolated use of individual parameters is insufficient for optimizing fetal therapy strategy and predicting the dynamics of fetal anemia.

  • Open Access

    Effectiveness of melatonin in the prevention of placenta­associated complications in high­risk pregnant women

    by Dariia Andreishyna, Svitlana Zhuk

    Objective: To evaluate the effectiveness of melatonin as part of comprehensive preventive therapy in pregnant women at risk of placenta-associated complications. Materials and Methods. A prospective clinical study was conducted involving 146 pregnant women. Group I included high-risk pregnant women, who were divided into a main subgroup (complex therapy with melatonin) and a comparison subgroup (standard therapy). The control group consisted of women with a physiological pregnancy. Hemostasis parameters, placental function, and pregnancy outcomes were evaluated. Results. Melatonin use as part of comprehensive therapy resulted in a more pronounced normalization of hemostasis parameters, improved uteroplacental blood flow, and a lower incidence of placenta-associated complications compared to standard therapy. Conclusions. Melatonin as part of comprehensive prevention improves hemostatic balance, enhances placental function, and optimizes pregnancy outcomes, supporting its potential clinical use.

  • Hemostatic system imbalance in the pre-eclampsia model in rats

    by G. M. Shayakhmetova, A. O. Pavlenko, S. I. Zhuk, O. V. Gornytska, I. V. Us, L. B. Bondarenko, N. V. Dobrelia, T. M. Platonova

    Background. Preeclampsia (PE) is a multisystem disorder in pregnancy, that results from placental ischemia, oxidative stress-induced placental damage and placental factors dissemination that cause systemic endothelial dysfunction. Patients with preeclampsia often develop a severe prothrombotic state, the mechanisms of which are not fully elucidated. Objectives. The aim of this study was to assess the informativeness of hemostatic system parameters that characterize the degree of coagulation pathway activation and anticoagulant pathway capacity capacity in experimental preeclampsia model in rats for predicting the development of thrombotic complications in PE. Methods. Wistar females rats were used in the study. To induce a preeclampsia-like syndrome, N(ω)-nitro-L-arginine methyl ester (L-NAME), at a concentration of 0.3 g/l in the drinking water was administered ad libitum from the 8th to the 14th day of gestation. On gestational day 21 the rats were anesthetized and blood samples were collected. Urinary and serum concentrations of creatinine, urea, and uric acid were determined using a fully automated Chemistry Analyzer and commercially available kits. Fibrinogen, soluble fibrin monomeric complexes and protein C concentrations, prothrombin time and antithrombin III activity in the blood plasma were estimated with a standard spectrophotometric methods. Results. Increased plasma fibrinogen, significant shortening of plasma clotting time, decrease in both protein C and AT III and increase in SFMCs plasma levels were detected in rats with experimentally L-NAME induced preeclampsia, indicating not only activation of the coagulation system but also disruption of the balance between procoagulant and anticoagulant pathways. Conclusions. L-NAME-induced PE in rats resulted in a pronounced imbalance of the hemostatic system and reproduced key pathophysiological features of PE, including excessive procoagulant shift, intravascular thrombin generation and impairment of anticoagulant mechanisms, making this model a valuable tool for studying mechanisms of disease progression. Analysis of hemostasis parameters in this model, indicates that soluble fibrin, protein C and antithrombin III are the most informative markers for assessing the risk of intravascular coagulation during preeclampsia. Keywords: antithrombin III, coagulation, fibrinogen, L-NAME induced preeclampsia model, preeclampsia, protein C, soluble fibrin, thrombosis

  • Open Access

    Fetal cardiovascular profile as a tool for early detection of hemodynamic decompensation in fetal anemia: integration with middle cerebral artery Doppler in pregnant women with Rh alloimmunization

    by S.I. Zhuk, Yu.M. Melnyk, M.M. Kryvoruk

    The objective: to evaluate the clinical significance of the fetal cardiovascular profile score (CVPS) as an integrated tool for early detection of hemodynamic decompensation in fetal anemia (FA) in pregnant women with Rh alloimmunization, and to assess its complementary role to middle cerebral artery (MCA) Doppler for guiding intrauterine treatment strategies.Materials and methods. A retrospective descriptive and analytical study included 18 pregnancies complicated by Rh alloimmunization, in which 42 cordocenteses with intrauterine transfusions (IUTs) were performed in 2025. Before each procedure, a comprehensive ultrasound assessment was conducted, including measurement of MCA peak systolic velocity and evaluation of the fetal CVPS. These parameters were used to stratify the degree of fetal cardiovascular adaptation and to determine the safest strategy and volume of IUT.Results. Integration of CVPS with MCA Doppler allowed to identify the different phases of fetal cardiovascular adaptation, ranging from compensated to subcompensated and decompensated states. Phenotype-based stratification allowed individualization of IUT strategy and was associated with stabilization of hemodynamic parameters and improved perinatal outcomes. Full-volume transfusion in fetuses with decompensated CVPS was associated with a higher risk of antenatal complications.Conclusions. CVPS is an informative tool for early detection of hemodynamic decompensation in FA. Its combination with MCA Doppler allows more precise assessment of fetal cardiac functional reserve, individualized IUT strategy, and improved safety of fetal therapy.

  • Open Access

    Doppler assessment in the middle cerebral artery as a key component of modern monitoring in rhesus-alloimmunized pregnancies

    by S.I. Zhuk, Yu.M. Melnyk, M.M. Kryvoruk, I.V. Ignatenko, Є.в. Ігнатенко

    Rhesus alloimmunization is one of the most severe forms of maternal–fetal immune conflict, resulting from maternal sensitization to Rhesus (Rh) erythrocyte antigens. The formation of anti-Rh antibodies leads to immune-mediated hemolysis of fetal red blood cells, causing progressive anemia, hypoxia, hydrops fetalis, and hemolytic disease of the fetus. Despite the use of anti-Rh immunoglobulin prophylaxis, Rh alloimmunization remain relevant and require high-precision prenatal monitoring. The basic of modern management is non-invasive assessment of fetal anemia severity to determine the optimal timing of invasive procedures. Among the available diagnostic tools, Doppler evaluation in the middle cerebral artery (MCA) is the most sensitive method, which reflects hemodynamic changes with a decrease in fetal hemoglobin level.The objective: to evaluate the clinical effectiveness of peak systolic velocity (PSV) in the MCA (MCA-PSV) as a marker of fetal anemia in Rh-alloimmunized pregnancies.Materials and methods. A retrospective analysis of 46 cases of Rh-alloimmunized pregnancies which were observed at the Gravimed Medical Center (clinical base of the Department of Obstetrics, Gynecology and Fetal Medicine of the Shupyk National Healthcare University of Ukraine) and the Department of Pregnancy Pathology of Kyiv Maternity Hospital No. 2 was conducted. An MCA-PSV value above 1.5 multiples of the median (MoM) was considered diagnostic for moderate or severe anemia.Results. Among 46 cases with of Rh-alloimmunized pregnancies, moderate and severe fetal anemia was diagnosed in 37 (80.4%) cases, of which 34 (73.9%) pregnant women underwent invasive interventions – cordocentesis with subsequent intrauterine hemotransfusion. An increased blood flow velocity in the MCA preceded the appearance of ultrasound signs of hydrops by 10–14 days and was significantly correlated with the level of anemia (r = 0.79; p < 0.001). After intrauterine hemotransfusion, normalization of MCA-PSV to 1.1–1.3 MoM was found within 48–72 hours.Conclusions. MCA Doppler is a highly sensitive and prognostically significant method for noninvasive diagnosis of fetal anemia in Rh alloimmunization. Its routine use as part of the monitoring algorithm allows for timely detection of hemodynamic abnormalities, optimization of indications for cordocentesis and blood transfusion, and reduction of the risk of severe perinatal complications.

  • Open Access

    Choice of therapy for aerobic vaginitis: a clinical and microbiological comparison

    by S.I. Zhuk, О.в. Забудський, D.D. Andreishyna, K.I. Derba

    Aerobic vaginitis (AV) is an inflammatory disease of the vagina that occurs as a result of dysbiosis of the vaginal environment with a predominance of aerobic opportunistic microorganisms, such as Escherichia coli, Staphylococcus aureus, Streptococcus spp., etc. Frequent recurrence and insufficient diagnosis determine the relevance of research into effective methods of therapy for this disease.The objective: to compare the clinical and microbiological efficacy of two vaginal combination preparations in the treatment of AV in non-pregnant women.Materials and methods. The study included 80 non-pregnant women aged 18 to 45 years with a confirmed diagnosis of AV. The patients were randomized into two equal groups: the main group received medication Tergynan (ternidazole, neomycin sulfate, nystatin, prednisolone sodium metasulfobenzoate), and the comparison group received another combination preparation (ornidazole, miconazole, neomycin sulfate, prednisolone). Diagnostics included microscopy, bacteriological examination of vaginal discharge, gynecological examination, and a patient questionnaire. Treatment effectiveness was evaluated on the 11th and 30th days after therapy.Results. Patients in the main group experienced faster clinical symptom relief (1–2 days earlier) and the frequency of complete recovery immediately after the end of therapy was 85% versus 62% in the comparison group. After 30 days, recurrence occurred in only 9% of women who used Tergynan versus 36% in the comparison group.Conclusions. Tergynan demonstrated significantly higher clinical and microbiological efficacy in the treatment of AV, which justifies its advantages as the drug of choice in the case of this pathology.

  • Open Access

    Placental Dysfunction Is Associated with Dysregulated Fibrinolytic System Activation

    by Tetiana Yatsenko, Iryna Us, Daria Korolova, Svitlana Zhuk, Halyna Dziuba, Alona Nalbat, Svitlana Kharchenko, Sandor George Vari, Volodymyr Chernyshenko

    During pregnancy, the maternal hemostatic system undergoes significant changes to support placental angiogenesis, maintain fetal blood flow, and ensure safe delivery. This study investigates the dysregulation of hemostasis in placental insufficiency and explores potential markers for diagnosing and managing this gestational complication. Thromboelastography, coagulation and fibrinolysis functional assays, ELISA, and immunoblotting were employed to assess hemostasis dysregulation in placental dysfunction of two cohorts of pregnant women with placental dysfunction and healthy controls. Thromboelastographic analysis revealed no significant differences in clot lysis indices between the control and placental dysfunction groups, with values remaining within normal ranges, suggesting this method’s limitations for assessing fibrinolysis in pregnancy. The placental dysfunction group demonstrated moderately increased fibrinogen levels and platelet sensitivity to ADP, indicating hemostasis reactiveness. Significantly lower D-dimer levels, decreased plasminogen activator inhibitor activity (total PAI-1 + PAI-2), and increased plasminogen activator activity, driven primarily by uPA in the placental dysfunction group, indicated abnormal fibrinolysis. Immunoblotting confirmed elevated uPA/uPA-PAI complexes and reduced tPA/tPA-PAI complexes, indicating that shutdown of tPA-mediated fibrinolysis and induction of uPA-driven vessel-wall-associated proteolysis are linked to placental dysfunction. Placental dysfunction involves fibrinolytic system dysregulation, marked by decreased PAI and tPA, uPA overproduction, and hypofibrinolysis, contributing to thrombotic risks, impaired placental flow, and complications like fetal growth retardation. PAI/PA ratio and D-dimer levels have diagnostic potential for placental-dysfunction-associated complications.


  • Open Access

    Water birth: evidence analysis, clinical recommendations and view of the problem

    by O.D. Shchurevska, S.I. Zhuk

    Water birth has become increasingly widespread in many countries around the world. However, attitudes toward this practice remain mixed, largely due to the lack of large-scale studies that provide scientific evidence validating all of its benefits and risks. In our country, immersion in water during labor is available in many maternity hospitals. However, the main issue is the absence of national guidelines and standards for managing such births. The existing order of the Ministry of Health of Ukraine dated January 26, 2022, No. 170 “Physiological Labor” recommends the use of hydrotherapy for pain relief during labor but does not provide clear requirements regarding its implementation.In this article, we reviewed current perspectives on the management strategies and potential complications of water birth. Hospitals which offer water birth must have clearly defined protocols that include: candidate selection, maintenance and cleaning of baths and pools, infection control procedures, temperature regulation, monitoring of the woman during labor and fetus, management of each labor stage, and evacuation of patients from the water in emergency situations (complications).Since immersion in water during the I stage of labor and the actual delivery of the baby into water may have different outcomes, we presented data on the advantages and risks of each. Immersion in water during the I stage of labor has a positive analgesic effect, contributes to the shortening of labor duration, and is not associated with an increased rate of maternal or fetal complications. Delivery of the baby directly into the water may be associated with possible neonatal risks such as infection, respiratory distress, water aspiration, umbilical cord avulsion, and others. We also present literature data on the management of labor in the presence of certain complications and conditions: group B streptococcus colonization, premature rupture of membranes, shoulder dystocia, elevated body mass index, and more.